New infant formula
Sponsors
Laboratorios Ordesa, Nutricia North America, United Pharmaceuticals, Jovie USA, LLC
Conditions
Congenital Heart DiseaseFunctional ConstipationFunctional Gastrointestinal DisordersGrowth FailureInfant DevelopmentWeight Gain
Unknown Phase
A Neurocognitive and Immunological Study of a New Formula for Healthy Infants
NCT02094547
Start: 2010-12-31End: 2020-10-31Updated: 2019-07-12
A Study to Evaluate the Effects of a New Formula on the Growth, Safety and Tolerance of Infants With Growth Failure
CompletedNCT03563391
Start: 2018-01-30End: 2020-05-30Updated: 2020-12-08
Evaluation of the Efficacy of a New Specific Infant Formula in Case of Functional Constipation
NCT05340712
Start: 2022-07-20End: 2024-09-30Target: 80Updated: 2022-11-07
Growth and Safety Clinical Trial on a New Infant Formula
CompletedNCT05508750
Start: 2022-09-21End: 2024-01-02Updated: 2024-01-17
Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula
RecruitingNCT06488274
Start: 2024-10-21End: 2026-04-30Target: 139Updated: 2025-01-06